Report Detail

Request for Sample of this report

Other Global Allogeneic Stem Cell Transplantation Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4554879
    • |
  • 02 September, 2023
    • |
  • Global
    • |
  • Pages: NA
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Allogeneic Stem Cell Transplantation market size was valued at USD 1029 million in 2022 and is forecast to a readjusted size of USD 1521 million by 2029 with a CAGR of 5.7% during review period.
The Global Info Research report includes an overview of the development of the Allogeneic Stem Cell Transplantation industry chain, the market status of Hospital (Unmodified Stem Cell Transplant, T-cell Depleted Transplant), Ambulatory Surgical Center (Unmodified Stem Cell Transplant, T-cell Depleted Transplant), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Allogeneic Stem Cell Transplantation.
Regionally, the report analyzes the Allogeneic Stem Cell Transplantation markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Allogeneic Stem Cell Transplantation market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Allogeneic Stem Cell Transplantation market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Allogeneic Stem Cell Transplantation industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Unmodified Stem Cell Transplant, T-cell Depleted Transplant).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Allogeneic Stem Cell Transplantation market.
Regional Analysis: The report involves examining the Allogeneic Stem Cell Transplantation market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Allogeneic Stem Cell Transplantation market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Allogeneic Stem Cell Transplantation:
Company Analysis: Report covers individual Allogeneic Stem Cell Transplantation players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Allogeneic Stem Cell Transplantation This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Ambulatory Surgical Center).
Technology Analysis: Report covers specific technologies relevant to Allogeneic Stem Cell Transplantation. It assesses the current state, advancements, and potential future developments in Allogeneic Stem Cell Transplantation areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Allogeneic Stem Cell Transplantation market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Allogeneic Stem Cell Transplantation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Unmodified Stem Cell Transplant
T-cell Depleted Transplant
Cord Blood Transplant
Donor Lymphocyte Infusion
Market segment by Application
Hospital
Ambulatory Surgical Center
Others
Market segment by players, this report covers
Mesoblast Limited
Gamida Cell Ltd.
Novartis International AG
Cellectis SA
Magenta Therapeutics Inc.
Fate Therapeutics Inc.
Cynata Therapeutics Limited
Kiadis Pharma N.V
Takeda Pharmaceutical Company Limited
JCR Pharmaceuticals Co., Ltd.
Pluristem Therapeutics Inc.
Celularity Inc.
Lineage Cell Therapeutics Inc.
Nohla Therapeutics Inc.
Orchard Therapeutics Plc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Allogeneic Stem Cell Transplantation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Allogeneic Stem Cell Transplantation, with revenue, gross margin and global market share of Allogeneic Stem Cell Transplantation from 2018 to 2023.
Chapter 3, the Allogeneic Stem Cell Transplantation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Allogeneic Stem Cell Transplantation market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Allogeneic Stem Cell Transplantation.
Chapter 13, to describe Allogeneic Stem Cell Transplantation research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Allogeneic Stem Cell Transplantation
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Allogeneic Stem Cell Transplantation by Type
    • 1.3.1 Overview: Global Allogeneic Stem Cell Transplantation Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Allogeneic Stem Cell Transplantation Consumption Value Market Share by Type in 2022
    • 1.3.3 Unmodified Stem Cell Transplant
    • 1.3.4 T-cell Depleted Transplant
    • 1.3.5 Cord Blood Transplant
    • 1.3.6 Donor Lymphocyte Infusion
  • 1.4 Global Allogeneic Stem Cell Transplantation Market by Application
    • 1.4.1 Overview: Global Allogeneic Stem Cell Transplantation Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Ambulatory Surgical Center
    • 1.4.4 Others
  • 1.5 Global Allogeneic Stem Cell Transplantation Market Size & Forecast
  • 1.6 Global Allogeneic Stem Cell Transplantation Market Size and Forecast by Region
    • 1.6.1 Global Allogeneic Stem Cell Transplantation Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Allogeneic Stem Cell Transplantation Market Size by Region, (2018-2029)
    • 1.6.3 North America Allogeneic Stem Cell Transplantation Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Allogeneic Stem Cell Transplantation Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size and Prospect (2018-2029)
    • 1.6.6 South America Allogeneic Stem Cell Transplantation Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Allogeneic Stem Cell Transplantation Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Mesoblast Limited
    • 2.1.1 Mesoblast Limited Details
    • 2.1.2 Mesoblast Limited Major Business
    • 2.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.1.4 Mesoblast Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Mesoblast Limited Recent Developments and Future Plans
  • 2.2 Gamida Cell Ltd.
    • 2.2.1 Gamida Cell Ltd. Details
    • 2.2.2 Gamida Cell Ltd. Major Business
    • 2.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.2.4 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Gamida Cell Ltd. Recent Developments and Future Plans
  • 2.3 Novartis International AG
    • 2.3.1 Novartis International AG Details
    • 2.3.2 Novartis International AG Major Business
    • 2.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.3.4 Novartis International AG Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novartis International AG Recent Developments and Future Plans
  • 2.4 Cellectis SA
    • 2.4.1 Cellectis SA Details
    • 2.4.2 Cellectis SA Major Business
    • 2.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.4.4 Cellectis SA Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Cellectis SA Recent Developments and Future Plans
  • 2.5 Magenta Therapeutics Inc.
    • 2.5.1 Magenta Therapeutics Inc. Details
    • 2.5.2 Magenta Therapeutics Inc. Major Business
    • 2.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.5.4 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Magenta Therapeutics Inc. Recent Developments and Future Plans
  • 2.6 Fate Therapeutics Inc.
    • 2.6.1 Fate Therapeutics Inc. Details
    • 2.6.2 Fate Therapeutics Inc. Major Business
    • 2.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.6.4 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Fate Therapeutics Inc. Recent Developments and Future Plans
  • 2.7 Cynata Therapeutics Limited
    • 2.7.1 Cynata Therapeutics Limited Details
    • 2.7.2 Cynata Therapeutics Limited Major Business
    • 2.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.7.4 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cynata Therapeutics Limited Recent Developments and Future Plans
  • 2.8 Kiadis Pharma N.V
    • 2.8.1 Kiadis Pharma N.V Details
    • 2.8.2 Kiadis Pharma N.V Major Business
    • 2.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.8.4 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Kiadis Pharma N.V Recent Developments and Future Plans
  • 2.9 Takeda Pharmaceutical Company Limited
    • 2.9.1 Takeda Pharmaceutical Company Limited Details
    • 2.9.2 Takeda Pharmaceutical Company Limited Major Business
    • 2.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.9.4 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
  • 2.10 JCR Pharmaceuticals Co., Ltd.
    • 2.10.1 JCR Pharmaceuticals Co., Ltd. Details
    • 2.10.2 JCR Pharmaceuticals Co., Ltd. Major Business
    • 2.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.10.4 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 JCR Pharmaceuticals Co., Ltd. Recent Developments and Future Plans
  • 2.11 Pluristem Therapeutics Inc.
    • 2.11.1 Pluristem Therapeutics Inc. Details
    • 2.11.2 Pluristem Therapeutics Inc. Major Business
    • 2.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.11.4 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Pluristem Therapeutics Inc. Recent Developments and Future Plans
  • 2.12 Celularity Inc.
    • 2.12.1 Celularity Inc. Details
    • 2.12.2 Celularity Inc. Major Business
    • 2.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.12.4 Celularity Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Celularity Inc. Recent Developments and Future Plans
  • 2.13 Lineage Cell Therapeutics Inc.
    • 2.13.1 Lineage Cell Therapeutics Inc. Details
    • 2.13.2 Lineage Cell Therapeutics Inc. Major Business
    • 2.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.13.4 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Lineage Cell Therapeutics Inc. Recent Developments and Future Plans
  • 2.14 Nohla Therapeutics Inc.
    • 2.14.1 Nohla Therapeutics Inc. Details
    • 2.14.2 Nohla Therapeutics Inc. Major Business
    • 2.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.14.4 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Nohla Therapeutics Inc. Recent Developments and Future Plans
  • 2.15 Orchard Therapeutics Plc
    • 2.15.1 Orchard Therapeutics Plc Details
    • 2.15.2 Orchard Therapeutics Plc Major Business
    • 2.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product and Solutions
    • 2.15.4 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Orchard Therapeutics Plc Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Allogeneic Stem Cell Transplantation Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Allogeneic Stem Cell Transplantation by Company Revenue
    • 3.2.2 Top 3 Allogeneic Stem Cell Transplantation Players Market Share in 2022
    • 3.2.3 Top 6 Allogeneic Stem Cell Transplantation Players Market Share in 2022
  • 3.3 Allogeneic Stem Cell Transplantation Market: Overall Company Footprint Analysis
    • 3.3.1 Allogeneic Stem Cell Transplantation Market: Region Footprint
    • 3.3.2 Allogeneic Stem Cell Transplantation Market: Company Product Type Footprint
    • 3.3.3 Allogeneic Stem Cell Transplantation Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Allogeneic Stem Cell Transplantation Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Allogeneic Stem Cell Transplantation Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Allogeneic Stem Cell Transplantation Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Allogeneic Stem Cell Transplantation Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Allogeneic Stem Cell Transplantation Consumption Value by Type (2018-2029)
  • 6.2 North America Allogeneic Stem Cell Transplantation Consumption Value by Application (2018-2029)
  • 6.3 North America Allogeneic Stem Cell Transplantation Market Size by Country
    • 6.3.1 North America Allogeneic Stem Cell Transplantation Consumption Value by Country (2018-2029)
    • 6.3.2 United States Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Allogeneic Stem Cell Transplantation Consumption Value by Type (2018-2029)
  • 7.2 Europe Allogeneic Stem Cell Transplantation Consumption Value by Application (2018-2029)
  • 7.3 Europe Allogeneic Stem Cell Transplantation Market Size by Country
    • 7.3.1 Europe Allogeneic Stem Cell Transplantation Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 7.3.3 France Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Allogeneic Stem Cell Transplantation Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Allogeneic Stem Cell Transplantation Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region
    • 8.3.1 Asia-Pacific Allogeneic Stem Cell Transplantation Consumption Value by Region (2018-2029)
    • 8.3.2 China Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 8.3.5 India Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Allogeneic Stem Cell Transplantation Consumption Value by Type (2018-2029)
  • 9.2 South America Allogeneic Stem Cell Transplantation Consumption Value by Application (2018-2029)
  • 9.3 South America Allogeneic Stem Cell Transplantation Market Size by Country
    • 9.3.1 South America Allogeneic Stem Cell Transplantation Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Allogeneic Stem Cell Transplantation Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Allogeneic Stem Cell Transplantation Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country
    • 10.3.1 Middle East & Africa Allogeneic Stem Cell Transplantation Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Allogeneic Stem Cell Transplantation Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Allogeneic Stem Cell Transplantation Market Drivers
  • 11.2 Allogeneic Stem Cell Transplantation Market Restraints
  • 11.3 Allogeneic Stem Cell Transplantation Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Allogeneic Stem Cell Transplantation Industry Chain
  • 12.2 Allogeneic Stem Cell Transplantation Upstream Analysis
  • 12.3 Allogeneic Stem Cell Transplantation Midstream Analysis
  • 12.4 Allogeneic Stem Cell Transplantation Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Allogeneic Stem Cell Transplantation. Industry analysis & Market Report on Allogeneic Stem Cell Transplantation is a syndicated market report, published as Global Allogeneic Stem Cell Transplantation Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Allogeneic Stem Cell Transplantation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,777.04
    		4,165.56
    		5,554.08
    		3,246.84
    		4,870.26
    		6,493.68
    		535,084.80
    		802,627.20
    		1,070,169.60
    		290,440.80
    		435,661.20
    		580,881.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo